Sanara MedTech(SMTI)2025-03-25 11:05Financial Results - Sanara MedTech Inc. announced preliminary financial results for Q4 and full year 2024 on January 21, 2025[5]. - The report does not include specific financial figures or performance metrics for Q4 or full year 2024[5]. - The report does not provide guidance for future performance or financial outlook[5]. Company Information - The company is listed on The Nasdaq Capital Market under the trading symbol SMTI[3]. - The company has not indicated whether it is an emerging growth company[4]. - The report is signed by Michael D. McNeil, Chief Accounting Officer and Chief Administrative Officer[10]. Report Details - The press release detailing financial results is included as Exhibit 99.1 in the report[5]. - The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934[1]. Strategic Initiatives - There is no mention of new product development or market expansion strategies in the current report[5]. - No information regarding mergers or acquisitions is included in the report[5].